You are on page 1of 2

Perthera Hosts Breakfast Symposium at the 2018 ASCO Annual Meeting

McLean, VA, May 22, 2018 --( Perthera, Inc., the leading Therapeutics Intelligence
Company™, will be hosting a networking breakfast and educational session on Monday, June 4th from
6:30 - 7:30 a.m. for attendees of the 2018 American Society of Clinical Oncology (ASCO) Annual
Meeting. The breakfast symposium will be held in the Regency D ballroom of the Hyatt Regency
McCormick Place, directly adjacent to the McCormick Place.

“We are very excited to host this breakfast symposium at the 2018 ASCO Annual Meeting. With this
event we hope to give ASCO attendees more information about who we are and what we do, and the good
we can do for oncology patients.” -Neal G. Koller, President & CEO, Perthera, Inc.

The breakfast symposium will feature 3 speakers:

Michael Pishvaian, M.D., Ph.D. presenting: The Perthera Experience of a Comprehensive Case Review
and Integration of Multi-omic Molecular Testing for 640 Cancer Patients Through the KYT Program
Chief Medical Officer at Perthera, Inc.
Director, Phase I Clinical Program
Co-Director, Ruesch Center Pancreatic Cancer Program
Lombardi Cancer Center, Georgetown University, Washington DC

Jonathan Brody, Ph.D. presenting: Integrating the Perthera Report into a High Volume Practice of
Pancreatic Cancer Patients
Director, Surgical Research
Co-Director, Jefferson Pancreas, Biliary and Related Cancer Center
Thomas Jefferson University, Philadelphia PA

Anthony Conley, M.D. presenting: Initial Experience with the Perthera Report in our Cancer Clinic
Assistant Professor, Department of Sarcoma Medical Oncology
The University of Texas MD Anderson Cancer Center, Houston TX

The 2018 ASCO Annual Meeting will be held at the McCormick Place Convention Center in Chicago
from June 1st - 5th, and will host over 25,000 oncology professionals from around the world. In addition
to the networking breakfast meeting, Perthera will exhibiting in booth #16024 and have executives on
hand during the conference to meet personally with attendees interested in learning more about our role in
personalized medicine for cancer treatment.

About Perthera, Inc.:

Perthera is the leading Therapeutic Intelligence Company advancing precision medicine through its
Perthera Report™, which precisely matches cancer patients with multiple therapeutic options ranked by
highest probability of best outcome.

Page 1/2 Press Release Distribution Terms of Use
Contact Information:
Perthera, Inc.
Phil Robertson
Contact via Email

Online Version of Press Release:

You can read the online version of this press release at:

News Image:

Page 2/2 Press Release Distribution Terms of Use